ClinicalTrials.Veeva

Menu

Antibiotic Prophylaxis When Removing Ureteric Stent After Stone Surgery

T

Tor Erik Sand

Status

Unknown

Conditions

Ureteric Stent After Stone Surgery

Treatments

Drug: Trimetoprim-Sulfa (Bactrim)
Other: No antibiotics

Study type

Interventional

Funder types

Other

Identifiers

NCT01768364
2012/953

Details and patient eligibility

About

Is there anything to gain in giving antibiotics as prophylaxis when removing ureteric stents cystoscopically after stone surgery?

Full description

Many patients undergoing stone surgery receive a ureteric stent that should be removed after 14 days. This stent is removed cystoscopically and today this is done without giving antibiotics. Some patients get urinary tract infections subject to this. However the investigators do not know how many of these patients get UTI as most are followed by their primary care doctor. With this study the investigators would like to find out whether it is possible to avoid such infections and also find out how many actually do get infected.

Enrollment

124 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stone surgery patients with ureteric stent that should be removed after 14 days

Exclusion criteria

  • ongoing antibiotic treatment, allergy to trimetoprim-sulfa

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

124 participants in 2 patient groups

Antibiotics
Active Comparator group
Description:
will receive antibiotics
Treatment:
Drug: Trimetoprim-Sulfa (Bactrim)
No antibiotics
Active Comparator group
Description:
will not receive antibiotics
Treatment:
Other: No antibiotics

Trial contacts and locations

1

Loading...

Central trial contact

Tor Erik Sand, MD, PhD; Manuela Estop-Garanto, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems